CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 10 enrolled
Drug / intervention
Vertex Pulmonary Embolectomy Systemdevice
Likely dose
Vertex Pulmonary Embolectomy System (mechanical device; no dose applicable)AI-extracted
Key inclusion· 5
  • ✓Age 18 to <80 years
  • ✓Acute PE symptoms onset ≤14 days
  • ✓CTA evidence of proximal PE (filling defect in main or interlobar pulmonary artery)
  • ✓RV/LV ratio >0.9 on CTA indicating right ventricular strain
Key exclusion· 31
  • ✕Thrombolytic use within 30 days
  • ✕Pulmonary artery pressure >70 mmHg on right heart catheterization
  • ✕Vasopressor requirement after fluids to maintain SBP ≥90 mmHg
  • ✕Heart rate >130 bpm prior to procedure

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06571760
NCT06571760N/ACompleted
CompareCT.gov

Selective Pulmonary-artery Intervention to Reduce Acute Right-heart tEnsion-I

Neptune Medical·interventional·Posted Aug 26, 2024·Updated May 19, 2026

In Brief

A clinical study evaluating Vertex Pulmonary Embolectomy System for Pulmonary Embolism. Completed, enrolled 10 participants across 2 sites in 2 countries.

Detailed Summary

This study study is a prospective, single-arm, multicenter study to evaluate the safety and effectiveness of the Vertex Pulmonary Embolectomy System in participants presenting with clinical signs and symptoms of pulmonary embolism.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPulmonary Embolism
CountriesAustria, Poland
Collaborators--

Timeline

N/ACompletedFinished
20252026
First PostedAug 26, 2024
Enrollment StartSep 10, 2024
Primary CompletionApr 24, 2025
Study CompletionMay 21, 2025
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 1.8 years ago

Interventions

Vertex Pulmonary Embolectomy Systemdevice

Use of Vertex Pulmonary Embolectomy System to treat pulmonary embolism.